These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21382127)

  • 1. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
    Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
    Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats.
    Hur E; Bozkurt D; Timur O; Bicak S; Sarsik B; Akcicek F; Duman S
    Clin Nephrol; 2012 Jan; 77(1):1-7. PubMed ID: 22185962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis.
    Bozkurt D; Sarsik B; Hur E; Ertilav M; Karaca B; Timur O; Bicak S; Akcicek F; Duman S
    J Nephrol; 2011; 24(3):359-65. PubMed ID: 21240876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tyrosine kinase inhibition with imatinib in an encapsulating peritoneal sclerosis rat model.
    Velioglu A; Tugtepe H; Asicioglu E; Yilmaz N; Filinte D; Arikan H; Koc M; Tuglular S; Kaya H; Ozener C
    Ren Fail; 2013; 35(4):531-7. PubMed ID: 23473055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
    Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
    Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
    Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
    Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
    Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
    Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis.
    Peng W; Zhou Q; Ao X; Tang R; Xiao Z
    Ren Fail; 2013 Aug; 35(7):958-66. PubMed ID: 23859538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.
    Bozkurt D; Bicak S; Sipahi S; Taskin H; Hur E; Ertilav M; Sen S; Duman S
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S53-7. PubMed ID: 19008543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models.
    Io H; Hamada C; Ro Y; Ito Y; Hirahara I; Tomino Y
    Kidney Int; 2004 May; 65(5):1927-36. PubMed ID: 15086936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.
    Kushiyama T; Oda T; Yamada M; Higashi K; Yamamoto K; Oshima N; Sakurai Y; Miura S; Kumagai H
    Nephrol Dial Transplant; 2011 Oct; 26(10):3143-54. PubMed ID: 21362737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis.
    Ada S; Ersan S; Sifil A; Unlu M; Kolatan E; Sert M; Sarioglu S; Yilmaz O; Camsari T
    Int Urol Nephrol; 2015 Dec; 47(12):2047-51. PubMed ID: 26433885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
    Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
    Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
    Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
    Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats.
    Ro Y; Hamada C; Inaba M; Io H; Kaneko K; Tomino Y
    Nephrol Dial Transplant; 2007 Oct; 22(10):2838-48. PubMed ID: 17545675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?
    Bozkurt D; Hur E; Ulkuden B; Sezak M; Nar H; Purclutepe O; Sen S; Duman S
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S202-5. PubMed ID: 19270218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
    Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
    Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution.
    Günal AI; Duman S; Sen S; Unsal A; Terzioğlu E; Akçiçek F; Basci A
    J Nephrol; 2001; 14(3):184-9. PubMed ID: 11439742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rapamycin on peritoneal fibrosis and transport function.
    Xu T; Xie JY; Wang WM; Ren H; Chen N
    Blood Purif; 2012; 34(1):48-57. PubMed ID: 22922738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.